DK0830376T3 - Fremgangsmåde til fremstilling af erythropoietin, som er fri for animalske proteiner - Google Patents

Fremgangsmåde til fremstilling af erythropoietin, som er fri for animalske proteiner

Info

Publication number: DK0830376T3
Authority: DK; Denmark
Prior art keywords: free; host cell; animal proteins; protein; producing erythropoietin
Prior art date: 1995-05-11

Application number

DK96919753T

Other languages

Danish (da)

English (en)

Inventor

Josef Burg

Walter Schneider

Alexander Wrba

Werner Fuerst

Karl-Heinz Sellinger

Original Assignee

Roche Diagnostics Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-05-11

Filing date

1996-05-10

Publication date

2004-05-24

1996-05-10 Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh

2004-05-24 Application granted granted Critical

2004-05-24 Publication of DK0830376T3 publication Critical patent/DK0830376T3/da

Links

102000003951 Erythropoietin Human genes 0.000 title abstract 2
108090000394 Erythropoietin Proteins 0.000 title abstract 2
229940105423 erythropoietin Drugs 0.000 title abstract 2
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 title abstract 2
235000021120 animal protein Nutrition 0.000 title 1
102000004169 proteins and genes Human genes 0.000 abstract 3
108090000623 proteins and genes Proteins 0.000 abstract 3
230000000694 effects Effects 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK96919753T 1995-05-11 1996-05-10 Fremgangsmåde til fremstilling af erythropoietin, som er fri for animalske proteiner DK0830376T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP95107165		1995-05-11
DE19522461		1995-06-21
PCT/EP1996/001988 WO1996035718A1 (fr)	1995-05-11	1996-05-10	Procede de production d'erytropoietine exempte de proteines animales

Publications (1)

Publication Number	Publication Date
DK0830376T3 true DK0830376T3 (da)	2004-05-24

Family

ID=26016131

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK96919753T DK0830376T3 (da)	1995-05-11	1996-05-10	Fremgangsmåde til fremstilling af erythropoietin, som er fri for animalske proteiner
DK03016548T DK1394179T3 (da)	1995-05-11	1996-05-10	Fremgangsmåde til fremstilling af erythropoietin fri for animalske proteiner

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK03016548T DK1394179T3 (da)	1995-05-11	1996-05-10	Fremgangsmåde til fremstilling af erythropoietin fri for animalske proteiner

Country Status (12)

Country	Link
US (2)	US6399333B1 (fr)
EP (2)	EP1394179B1 (fr)
JP (1)	JP3061200B2 (fr)
AT (2)	ATE258189T1 (fr)
AU (1)	AU5817496A (fr)
CA (1)	CA2220515C (fr)
DE (2)	DE59611371D1 (fr)
DK (2)	DK0830376T3 (fr)
ES (2)	ES2268232T3 (fr)
IL (2)	IL118201A (fr)
PT (2)	PT1394179E (fr)
WO (1)	WO1996035718A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU729459B2 (en) *	1996-11-15	2001-02-01	Genentech Inc.	Purification of neurotrophins
JP4541539B2 (ja) *	1997-07-23	2010-09-08	ロシュダイアグノスティックスゲーエムベーハー	内因性遺伝子活性化によるエリスロポエチンの製造
US6548296B1 (en) *	1997-07-23	2003-04-15	Roche Diagnostics Gmbh	Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
WO1999028346A1 (fr)	1997-12-03	1999-06-10	Roche Diagnostics Gmbh	Erythropoietine a activite specifique marquee
NZ507557A (en)	1998-05-06	2003-10-31	Genentech Inc	Protein purification by ion exchange chromatography
BR9917606A (pt) *	1998-11-06	2002-12-31	Bio Sidus S A	Procedimento para a purificação de eritropoetina humana recombinante a partir de sobrenadantes de cultivo de células e eritropoetina humana recombinante obtida com tal procedimento
BR9905868A (pt)	1998-11-06	2001-01-23	Bio Sidus S A	Procedimento de cultivo massivo de células de mamìfero para a obtenção de eritropoetina humana, recombinante e a eritropoetina humana recombinante obtida com tal procedimento
BR9905867A (pt) *	1998-11-06	2001-01-23	Bio Sidus S A	Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula
JO2291B1 (en)	1999-07-02	2005-09-12	اف . هوفمان لاروش ايه جي	Erythropoietin derivatives
AU2002233230B2 (en)	2000-12-20	2007-02-01	F. Hoffmann-La Roche Ag	Erythropoietin conjugates
CN1596310A (zh) *	2001-11-28	2005-03-16	桑多斯有限公司	产生重组多肽的方法
ATE363541T1 (de) *	2002-03-26	2007-06-15	Lek Tovarna Farmacevtskih	Verfahren für die herstellung eines gewünschten profils von erythropoietin glyko-isoformen
DE60228460D1 (de) *	2002-12-13	2008-10-02	Bioceuticals Arzneimittel Ag	Verfahren zur Herstellung und Reinigung von Erythropoietin
US20050019914A1 (en) *	2003-07-24	2005-01-27	Aventis Pharma Deutschland Gmbh	Perfusion process for producing erythropoietin
EP1670821A4 (fr) *	2003-10-09	2006-11-29	Daewoong Co Ltd	Procede de purification de la thrombopoietine humaine a teneur en acide sialique elevee
DE102004027816A1 (de) *	2004-06-08	2006-01-05	Bioceuticals Arzneimittel Ag	Verfahren zur Reinigung von Erythropoietin
US7598356B2 (en) *	2004-07-08	2009-10-06	Board of Regents of the University of Nebraska by and on behalf of the University of Nebraska Medical Center	Method for purifying a protein of the cystine-knot superfamily
DE602004013847D1 (de) *	2004-11-09	2008-06-26	Usv Ltd	Neues verfahren zur aufreinigung von humanem wachstumshormon
ES2509872T3 (es) *	2005-03-03	2014-10-20	Allergan, Inc.	Procedimientos para obtener una toxina clostrídica
EP2495308A1 (fr)	2005-12-08	2012-09-05	Amgen Inc.	Production améliorée de glycoprotéines au moyen de manganèse
PL2054074T3 (pl)	2006-08-04	2015-03-31	Prolong Pharmaceuticals Llc	Zmodyfikowana erytropoetyna
EP2089424B1 (fr) *	2006-12-06	2015-07-01	JCR PHARMACEUTICALS Co., LTD.	Procédé de production d'érythropoïétine humaine
KR100988706B1 (ko)	2007-03-07	2010-10-18	한미홀딩스 주식회사	재조합 에리트로포이에틴의 신규한 정제방법
CL2008002053A1 (es)	2007-07-17	2009-05-22	Hoffmann La Roche	Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
AR067536A1 (es) *	2007-07-17	2009-10-14	Hoffmann La Roche	Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
KR100900033B1 (ko)	2007-11-21	2009-06-01	한국생명공학연구원	인간 에리스로포이에틴의 정제방법
MX344166B (es)	2008-02-08	2016-12-07	Ambrx Inc	Leptina-polipeptidos modificados y sus usos.
DE102008002210A1 (de) *	2008-06-04	2009-12-10	Evonik Degussa Gmbh	Verfahren zur fermentativen Herstellung von Erythropoietin
DE102008002209A1 (de)	2008-06-04	2009-12-10	Evonik Degussa Gmbh	Verfahren zur Aufreinigung von Erythropoietin
CN102164954B (zh)	2008-09-23	2018-04-06	弗·哈夫曼-拉罗切有限公司	促红细胞生成素的纯化
BR122012024318A2 (pt)	2008-09-26	2019-07-30	Ambrx, Inc.	Polipeptídeos modificados de eritropoetina animal e seus usos
DE102008054716A1 (de)	2008-12-16	2010-06-17	Evonik Degussa Gmbh	Inprozesskontrolle in einem Verfahren zur Herstellung von EPO
US20120177640A1 (en)	2009-07-24	2012-07-12	Josef Burg	Optimizing the production of antibodies
EA022396B1 (ru)	2009-09-23	2015-12-30	Ратиофарм Гмбх	Способ очистки рекомбинантного эритропоэтина человека (epo), эритропоэтин, очищенный данным способом, и фармацевтические композиции, содержащие такой эритропоэтин
KR101443257B1 (ko) *	2011-10-18	2014-09-19	주식회사 종근당	낮은 등전점을 갖는 에리스로포이에틴 유사체의 정제방법
US10066001B2 (en)	2013-03-15	2018-09-04	Apotex Inc.	Enhanced liquid formulation stability of erythropoietin alpha through purification processing
WO2016116966A1 (fr) *	2015-01-22	2016-07-28	Jcr Pharmaceuticals Co., Ltd.	Procédé de purification d'une alpha-galactosidase a recombinante humaine à partir de matériel contenant des protéines contaminantes des cellules hôtes
DK3613486T3 (da) *	2018-08-24	2021-01-04	Uga Biopharma Gmbh	Metode og anlæg til rengøring af epo og/eller et epo-derivat

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ210501A (en) *	1983-12-13	1991-08-27	Kirin Amgen Inc	Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4677195A (en) *	1985-01-11	1987-06-30	Genetics Institute, Inc.	Method for the purification of erythropoietin and erythropoietin compositions
IL79176A (en) *	1985-06-20	1992-06-21	Kirin Amgen Inc	Process for the recovery of erythropoietin from a fluid
US4954437A (en) *	1986-09-15	1990-09-04	Integrated Genetics, Inc.	Cell encoding recombinant human erythropoietin
AU4104889A (en)	1988-09-07	1990-03-15	Bioclones (Pty) Ltd	Purification of erythropoietin
DE4115722A1 (de) *	1991-05-14	1992-11-19	Boehringer Mannheim Gmbh	Serumfreies medium zur kultivierung von saeugerzellen

1996
- 1996-05-09 IL IL11820196A patent/IL118201A/en not_active IP Right Cessation
- 1996-05-10 AT AT96919753T patent/ATE258189T1/de active
- 1996-05-10 ES ES03016548T patent/ES2268232T3/es not_active Expired - Lifetime
- 1996-05-10 ES ES96919753T patent/ES2211961T3/es not_active Expired - Lifetime
- 1996-05-10 EP EP03016548A patent/EP1394179B1/fr not_active Expired - Lifetime
- 1996-05-10 US US08/945,802 patent/US6399333B1/en not_active Expired - Lifetime
- 1996-05-10 WO PCT/EP1996/001988 patent/WO1996035718A1/fr not_active Ceased
- 1996-05-10 DK DK96919753T patent/DK0830376T3/da active
- 1996-05-10 EP EP96919753A patent/EP0830376B1/fr not_active Expired - Lifetime
- 1996-05-10 CA CA002220515A patent/CA2220515C/fr not_active Expired - Lifetime
- 1996-05-10 AT AT03016548T patent/ATE334146T1/de active
- 1996-05-10 DE DE59611371T patent/DE59611371D1/de not_active Expired - Lifetime
- 1996-05-10 PT PT03016548T patent/PT1394179E/pt unknown
- 1996-05-10 AU AU58174/96A patent/AU5817496A/en not_active Abandoned
- 1996-05-10 PT PT96919753T patent/PT830376E/pt unknown
- 1996-05-10 DE DE59610898T patent/DE59610898D1/de not_active Expired - Lifetime
- 1996-05-10 DK DK03016548T patent/DK1394179T3/da active
- 1996-05-10 JP JP8533775A patent/JP3061200B2/ja not_active Expired - Lifetime
2002
- 2002-02-07 US US10/067,235 patent/US6471500B1/en not_active Expired - Lifetime
2003
- 2003-08-28 IL IL15764403A patent/IL157644A0/xx unknown

Also Published As

Publication number	Publication date
IL118201A0 (en)	1996-09-12
PT1394179E (pt)	2006-11-30
DE59610898D1 (de)	2004-02-26
WO1996035718A1 (fr)	1996-11-14
JP3061200B2 (ja)	2000-07-10
JPH10506924A (ja)	1998-07-07
ATE334146T1 (de)	2006-08-15
ATE258189T1 (de)	2004-02-15
PT830376E (pt)	2004-05-31
CA2220515C (fr)	2003-07-22
EP1394179A1 (fr)	2004-03-03
EP0830376B1 (fr)	2004-01-21
US6471500B1 (en)	2002-10-29
ES2211961T3 (es)	2004-07-16
AU5817496A (en)	1996-11-29
IL157644A0 (en)	2004-03-28
DK1394179T3 (da)	2006-11-20
US20020146771A1 (en)	2002-10-10
IL118201A (en)	2004-12-15
EP1394179B1 (fr)	2006-07-26
CA2220515A1 (fr)	1996-11-14
DE59611371D1 (de)	2006-09-07
EP0830376A1 (fr)	1998-03-25
ES2268232T3 (es)	2007-03-16
US6399333B1 (en)	2002-06-04

Publication	Publication Date	Title
DK0830376T3 (da)	2004-05-24	Fremgangsmåde til fremstilling af erythropoietin, som er fri for animalske proteiner
PT850310E (pt)	2005-05-31	Molecula de dna circular com origem de replicacao condicional, metodo para a sua preparacao e utilizacao da mesma na terapia genica
LU90855I2 (en)	2002-01-24	Proteine 1 osteogenique recombinante humaine: bmp-7 et ses d-riv-s pharmaceutiquement acceptables
DK0454898T3 (da)	1996-04-15	Glycosaminoglycan-modificeret protein, fremgangsmåde til fremstilling af proteinet, farmaceutiske præparater indeholdende proteinet samt anvendelse af proteinet
DK374087A (da)	1988-01-19	Fremgangsmaade til fremstilling af proteiner med faktor viii-aktivitet ved hjaelp af mikrobielle voertsceller og ekspressionsvektorer, vaertsceller og antistoffer til anvendelse ved denne
NO904023D0 (no)	1990-09-14	Blanding som induserer binding.
DK388789A (da)	1990-02-10	Hybridderivat af humant protein d, dets fremstilling og anvendelse samt dna, som koder derfor, og genstruktur og vaertscelle indeholdende denne dna
DK619086A (da)	1987-06-22	Gm-csf-protein, derivater deraf, samt fremstilling og anvendelse af saadanne proteiner
DK0629238T3 (da)	2000-12-18	Autotaxin:Motilitetsstimulerende protein, som er nyttigt til cancerdiagnose og terapi
NO963806D0 (no)	1996-09-11	Rekombinante viruser som koder for en glutamat-dekarboksylase (GAD)aktivitet
KR910006484A (ko)	1991-04-29	아밀로이드 전구체 단백질 프로머터 이를 이용한 아밀로이드 전구체 단백질의 발현 조절 방법 및 이를 이용한 알쯔하이머 병 치료 방법
AU7340487A (en)	1987-12-03	Human protein s, a plasma protein regulator of hemostasis
DE69813573D1 (de)	2003-05-22	Verbesserungen der oder in bezug auf die regulierung der t-zellaktivation
NO179453C (no)	1996-10-09	Fremgangsmåte for fremstilling av terapeutisk aktivt amphiregulin, vertscelle som produserer proteinet, rekombinant vektor inneholdt i vertscellen, samt nukleotidsekvens som koder for proteiner med amphiregulinaktivitet
MA21449A1 (fr)	1989-07-01	Abri-serres pour culture haute : (bananier, papaye, ..)